CLINICAL_TRIALS
trial_result
· 2021-06-18
Clinical Trial Update: Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist. [Phase 2]
Summary
Phase 2 clinical trial evaluating estetrol's impact on testosterone suppression and quality of life in prostate cancer patients on an LHRH agonist has been comp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pantarhei Oncology B.V. | Conditions: Prostatic Neoplasm | Phase 2 | Status: COMPLETED